Drug Enforcement D-0575-2025

Subpotent drug

Status

Ongoing

Classification

Class II

Report Date

August 20, 2025

Termination Date

—

Product Information

Product description
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
Product quantity
29, 004 bottles
Reason for recall
Subpotent drug
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Within U.S

Location & Firm

Recalling firm
PFIZER
Address
66 Hudson Blvd, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0575-2025
Event ID
97334
Recall initiation date
July 29, 2025
Center classification date
August 8, 2025
Code info
Lot #: 24C11, Exp 2/28/2026.
More code info
—